About Blue Dolphin Lead Discovery
Blue Dolphin Lead Discovery is a company based in San Rafael (United States) founded in 2000 by John Irwin and Brian Shoichet. It operates as a B2B. Blue Dolphin Lead Discovery offers products and services including Virtual Screening and Library Design. Blue Dolphin Lead Discovery operates in a competitive market with competitors including Aganitha, Cellumen, PointCross, IOTA Pharma and Emergentec, among others.
- Headquarter San Rafael, United States
- Founders John Irwin, Brian Shoichet
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Blue Dolphin Lead Discovery Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Blue Dolphin Lead Discovery
Blue Dolphin Lead Discovery offers a comprehensive portfolio of products and services, including Virtual Screening and Library Design.
Computer-based screening to identify potential ligands for drug targets.
Designing compound libraries for pharmaceutical research applications.
Funding Insights of Blue Dolphin Lead Discovery
Investments & Acquisitions by Blue Dolphin Lead Discovery
Financial Statements - Blue Dolphin Lead Discovery
Blue Dolphin Lead Discovery Comparisons
Competitors of Blue Dolphin Lead Discovery
Blue Dolphin Lead Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aganitha, Cellumen, PointCross, IOTA Pharma and Emergentec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-powered drug discovery and development solutions
|
|
| domain | founded_year | HQ Location |
Systems biology solutions for drug safety and efficacy are provided.
|
|
| domain | founded_year | HQ Location |
Big data platform & desktop software for preclinical & clinical research & regulatory applications
|
|
| domain | founded_year | HQ Location |
Offers fragment-based drug discovery products and services.
|
|
| domain | founded_year | HQ Location |
Computational solutions and consulting for better decision making in biomarker, target and drug development.
|
|
| domain | founded_year | HQ Location |
Offers AI and machine learning for in-silico drug discovery and bioinformatics services.
|
Latest news on Blue Dolphin Lead Discovery
Frequently Asked Questions about Blue Dolphin Lead Discovery
Blue Dolphin Lead Discovery was founded in 2000.
Blue Dolphin Lead Discovery is headquartered in San Rafael, United States. It is registered at San Rafael, California, United States.
Blue Dolphin Lead Discovery LLC is a contract research organization specializing in computer and structure-based ligand discovery. They provide fee-for-service virtual screening and library design to biotech and pharmaceutical clients. The process includes initial consultations, preliminary screens, and final reports based on testing. They do not retain intellectual property and collaborate with companies lacking in-house expertise. Operating from the United States, they focus on targets like proteins for drug development.
Blue Dolphin Lead Discovery's top competitors include Aganitha, Cellumen and PointCross.
Blue Dolphin Lead Discovery offers Virtual Screening and Library Design.